Prospects of Biosimilars and Follow-On Biologics Market

Wednesday, June 30, 2010 General News J E 4
Biosimilars and Follow-On Biologics: Global Market Outlook 2010-2025 report ( ) which gives in 2009 the biological (biologic) drug market generated over $125bn in revenues worldwide. There is great demand for lower-cost biological drugs. Commercial and regulatory developments will make biosimilars and follow-on biologics seize market share - our new report explains how. Many biologic patents will expire during our forecast period. There is mounting pressure from governments insurers and patients groups to reduce drug costs. Biologic drugs - noted as some of the most-expensive medicines - are prime targets. Developments facilitating biosimilars/follow-on biologics are gaining momentum with commercial opportunities for the taking. The potential revenues are significant. Biosimilars and Follow-On Biologics: Global Market Outlook 2010-2025 will provide you with information that you need to understand current trends and future possibilities for those drugs. This report predicts how the biosimilars market will develop from 2010 onwards. We discuss the biosimilar/follow-on drugs and manufacturers most likely to achieve success in coming years. Biologic drug classes covered in this report include: * Monoclonal antibodies * Fusion proteins * Erythropoietin * Growth hormones * Insulin products * Colony stimulating factors and interleukin-2 drugs * Interferons We discuss prospects for each class with biosimilar/follow-on targets identified and market forecasts to 2025 provided along with supporting information. Comprehensive analysis of the biosimilars/follow-on biologics sector Biosimilars and Follow-On Biologics: Global Market Outlook 2010-2025 examines that sector through a comprehensive review of information sources. We use primary and secondary research. This report provides unique sales forecasts market share analyses discussions of R&D pipeline developments and analyses of commercial drivers and restraints including SWOT analysis. There are over 70 tables and figures included as well as four interviews with experts. The result is a comprehensive market- and industry-centred study with detailed analyses and informed opinion to benefit your work. To know more and to buy a copy of your report feel free to visit : Related Reports The World Market for Biosimilars and the Potential for US Follow-on Biologics Biosimilars Series Forecast Analysis Or Contact us at : Bharat Book Bureau Tel: +91 22 27578668 Fax: +91 22 27579131 Email: Website: Follow us on twitter:


You May Also Like

View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
Lower Back Pain and Surgery: Literature Review Dis...
MultiVu Digital Center Feed: Dr. Shah, USAID Admi...